FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386293485> ?p ?o ?g. }

• W4386293485 abstract "Background Myocardial infarction (MI) is a common cardiovascular disease (CVD) in critically ill patients, leading to 17% mortality in the intensive care unit (ICU) setting. Patients with CVD frequently suffer from thiamine insufficiency, thereby thiamine supplements may be helpful. Unfortunately, the relationship between thiamine treatment and survival outcomes in ICU patients with MI is still unknown. The purpose of the research is to demonstrate the survival advantage of thiamine application in these patients. Methods The Medical Information Mart of Intensive Care-IV database served as the foundation for this retrospective cohort analysis. Depending on whether patients were given thiamine therapy during the hospital stay, critically ill MI patients were split into the thiamine and non-thiamine groups. The Kaplan–Meier (KM) method and Cox proportional hazard models were used to evaluate the relationship between thiamine use and the risk of in-hospital, 30-day, and 90-day mortality. To validate the results, a 1:2 closest propensity-score matching (PSM) was also carried out. Results This study included 1782 patients for analysis with 170 and 1,612 individuals in the thiamine and non-thiamine groups, respectively. The KM survival analyses revealed that the risk of in-hospital, 30-day, and 90-day mortality was significantly lower in the thiamine group than the none-thiamine group. After modifying for a variety of confounding factors, the Cox regression models demonstrated substantial positive impacts of thiamine use on in-hospital, 30-d, and 90-d mortality risk among critically ill patients with MI with hazard ratio being 0.605 [95% confidence interval (CI): 0.397–0.921, p = 0.019], 0.618 (95% CI: 0.398–0.960, p = 0.032), and 0.626 (95% CI: 0.411–0.953, p = 0.028), respectively, in the completely modified model. PSM analyses also obtained consistent results. Conclusion Thiamine supplementation is related to a decreased risk of mortality risk in critically ill patients with MI who are admitted to the ICU. More multicenter, large-sample, and well-designed randomized controlled trials are needed to validate this finding." @default.
• W4386293485 created "2023-08-31" @default.
• W4386293485 creator A5005075235 @default.
• W4386293485 creator A5012368167 @default.
• W4386293485 creator A5022526821 @default.
• W4386293485 creator A5032477676 @default.
• W4386293485 creator A5036882740 @default.
• W4386293485 creator A5041388801 @default.
• W4386293485 creator A5045354198 @default.
• W4386293485 creator A5054352845 @default.
• W4386293485 creator A5067934090 @default.
• W4386293485 creator A5072889877 @default.
• W4386293485 date "2023-08-29" @default.
• W4386293485 modified "2023-10-18" @default.
• W4386293485 title "Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction" @default.
• W4386293485 cites W1937013587 @default.
• W4386293485 cites W1948854550 @default.
• W4386293485 cites W1984399782 @default.
• W4386293485 cites W2000164041 @default.
• W4386293485 cites W2004342239 @default.
• W4386293485 cites W213628847 @default.
• W4386293485 cites W2241408506 @default.
• W4386293485 cites W2469622925 @default.
• W4386293485 cites W2560240742 @default.
• W4386293485 cites W2587964783 @default.
• W4386293485 cites W2608153727 @default.
• W4386293485 cites W2747380632 @default.
• W4386293485 cites W2809000554 @default.
• W4386293485 cites W2809524734 @default.
• W4386293485 cites W2826154294 @default.
• W4386293485 cites W2884987392 @default.
• W4386293485 cites W2885025259 @default.
• W4386293485 cites W2926155689 @default.
• W4386293485 cites W2967305704 @default.
• W4386293485 cites W2971128094 @default.
• W4386293485 cites W2990371696 @default.
• W4386293485 cites W3000453819 @default.
• W4386293485 cites W3011612860 @default.
• W4386293485 cites W3112371360 @default.
• W4386293485 cites W3113087825 @default.
• W4386293485 cites W3167258811 @default.
• W4386293485 cites W4206757735 @default.
• W4386293485 cites W4213108779 @default.
• W4386293485 cites W4229027723 @default.
• W4386293485 cites W4283328838 @default.
• W4386293485 cites W4285719527 @default.
• W4386293485 cites W4360617148 @default.
• W4386293485 doi "https://doi.org/10.3389/fnut.2023.1227974" @default.
• W4386293485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37706212" @default.
• W4386293485 hasPublicationYear "2023" @default.
• W4386293485 type Work @default.
• W4386293485 citedByCount "0" @default.
• W4386293485 crossrefType "journal-article" @default.
• W4386293485 hasAuthorship W4386293485A5005075235 @default.
• W4386293485 hasAuthorship W4386293485A5012368167 @default.
• W4386293485 hasAuthorship W4386293485A5022526821 @default.
• W4386293485 hasAuthorship W4386293485A5032477676 @default.
• W4386293485 hasAuthorship W4386293485A5036882740 @default.
• W4386293485 hasAuthorship W4386293485A5041388801 @default.
• W4386293485 hasAuthorship W4386293485A5045354198 @default.
• W4386293485 hasAuthorship W4386293485A5054352845 @default.
• W4386293485 hasAuthorship W4386293485A5067934090 @default.
• W4386293485 hasAuthorship W4386293485A5072889877 @default.
• W4386293485 hasBestOaLocation W43862934851 @default.
• W4386293485 hasConcept C10515644 @default.
• W4386293485 hasConcept C126322002 @default.
• W4386293485 hasConcept C167135981 @default.
• W4386293485 hasConcept C177713679 @default.
• W4386293485 hasConcept C17923572 @default.
• W4386293485 hasConcept C207103383 @default.
• W4386293485 hasConcept C2776203871 @default.
• W4386293485 hasConcept C2776376669 @default.
• W4386293485 hasConcept C2987404301 @default.
• W4386293485 hasConcept C44249647 @default.
• W4386293485 hasConcept C500558357 @default.
• W4386293485 hasConcept C50382708 @default.
• W4386293485 hasConcept C71924100 @default.
• W4386293485 hasConcept C77350462 @default.
• W4386293485 hasConceptScore W4386293485C10515644 @default.
• W4386293485 hasConceptScore W4386293485C126322002 @default.
• W4386293485 hasConceptScore W4386293485C167135981 @default.
• W4386293485 hasConceptScore W4386293485C177713679 @default.
• W4386293485 hasConceptScore W4386293485C17923572 @default.
• W4386293485 hasConceptScore W4386293485C207103383 @default.
• W4386293485 hasConceptScore W4386293485C2776203871 @default.
• W4386293485 hasConceptScore W4386293485C2776376669 @default.
• W4386293485 hasConceptScore W4386293485C2987404301 @default.
• W4386293485 hasConceptScore W4386293485C44249647 @default.
• W4386293485 hasConceptScore W4386293485C500558357 @default.
• W4386293485 hasConceptScore W4386293485C50382708 @default.
• W4386293485 hasConceptScore W4386293485C71924100 @default.
• W4386293485 hasConceptScore W4386293485C77350462 @default.
• W4386293485 hasLocation W43862934851 @default.
• W4386293485 hasLocation W43862934852 @default.
• W4386293485 hasOpenAccess W4386293485 @default.
• W4386293485 hasPrimaryLocation W43862934851 @default.
• W4386293485 hasRelatedWork W1995982834 @default.
• W4386293485 hasRelatedWork W1997539222 @default.
• W4386293485 hasRelatedWork W2026094606 @default.
• W4386293485 hasRelatedWork W2136543019 @default.

• next